REFERENCES
- Newcomb MD. Identifying high-risk youth: prevalence and patterns of adolescent drug abuse. In: Adolescent Drug Abuse: Clinical Assessment and Therapeutic Interventions (NIDA Research Monograph 156). Rahdert E, Czechowicz D, eds. Rockville, MD: US Department of Health and Human Services, 1995; 7–38.
- Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2005. (NIH Publication No. 06-5882). Bethesda, MD: National Institute on Drug Abuse, 2006.
- American Medical Association. Guidelines for Adolescent Preventive Services (GAPS). Available at: http://www.ama-assn.org/ama/pub/category/1980.html. Accessed November 8, 2006.
- Kulig JW, American Academy of Pediatrics: Committee on Substance Abuse. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention, identification, and management of substance abuse. Pediatrics 2005; 115(3):816–821.
- Wilson CR, Sherritt L, Gates E, Knight JR. Are clinical impressions of adolescent substance use accurate? Pediatrics 2004; 114(5):536–540.
- Winters KC. The Personal Experience Screening Questionnaire and Manual. Los Angeles, CA: Western Psychological Services, 1991.
- Rahdert E. The Adolescent Assessment and Referral Manual. (DHHS Publication ADM-91-1735). Rockville, MD: National Institute on Drug Abuse, 1991.
- Miller G. The Substance Abuse Subtle Screening Inventory-Adolescent Version. Bloomington, IN: SASSI Institute, 1990.
- Brener ND, Billy J, Grady WR. Assessment of factors affecting the validity of self-reported health-risk behavior among adolescents: Evidence from the scientific literature. J Adolesc Health 2003; 33(6):436–457.
- Kann L, Brener N, Warren CW, Collins JL, Giovino GA. An assessment of the effect of data collection setting on the prevalence of health risk behaviors among adolescents. J Adolesc Health 2002; 31(4):327–335.
- Johnson PB, Richter L. Research note: What if we're wrong? Some possible implications of systematic distortions in adolescents' self-reports of sensitive behaviors. J Drug Issues 2004; 34(4):951–970.
- Malvin IH, Moskowitz JM. Anonymous versus identifiable self-reports of adolescent drug attitudes, intentions, and use. Public Opin Q 1983; 47(4):557–566.
- O'Malley PM, Johnston LD, Bachman JG, Schulenberg J. A comparison of confidential versus anonymous survey procedures: Effects on reporting of drug use and related attitudes and beliefs in a national study of students. J Drug Issues 2000; 30(1):35–54.
- Winters KC. Development of an adolescent alcohol and other drug abuse screening scale: Personal Experience Screening Questionnaire. Addictive Behaviors 1992; 17(5):479–490.
- Richter L, Johnson PB. Current methods of assessing substance use: A review of strengths, problems, and developments. J Drug Issues 2001; 31(4):809–832.
- Meyers K, Hagan TA, Zanis D, Webb A, Frantz J, Ring-Kurtz S, Rutherford M, McLellan AT. Critical issues in adolescent substance use assessment. Drug Alcohol Depend 1999; 55(3):235–246.
- Ford CA, Millstein SG, Halpren-Felsher BL, Irwin CE Jr. Influence of physician confidentiality assurances on adolescents' willingness to disclose information and seek future health care. A randomized controlled trial. JAMA 1997; 278(12):1029–1034.